SOST and type 2 diabetes mellitus: For example, one study revealed that a reduction in sclerostin levels was associated with an increased risk of MI, type 2 diabetes, and coronary artery calcification, whereas lower sclerostin levels were correlated with a higher risk of MI and hypertension [31].